SCOPUS 정보 검색 플랫폼

Volumn 59, Issue 1, 2012, Pages

Effect of a reduction in uric acid on renal outcomes during losartan treatment: A post hoc analysis of the reduction of end points in noninsulin-dependent diabetes mellitus with the angiotensin II antagonist losartan trial

(2) Dhaun, Neeraj a Webb, David J b

a ROYAL INFIRMARY OF EDINBURGH (United Kingdom)

b UNIVERSITY OF EDINBURGH (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOSARTAN; PLACEBO; URIC ACID;

BLOOD PRESSURE REGULATION; DISEASE MARKER; HUMAN; LETTER; MOLECULAR MECHANICS; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL PROTECTION; RISK FACTOR; RISK REDUCTION; URIC ACID BLOOD LEVEL; URIC ACID NEPHROPATHY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; LOSARTAN; MALE; URIC ACID;

EID: 83655191491 PISSN: 0194911X EISSN: 15244563 Source Type: Journal
DOI: 10.1161/HYPERTENSIONAHA.111.186064 Document Type: Letter

Times cited : (2)

References (5)

1
- 79959709376
- Effect of a reduction in uric acid on renal outcomes during losartan treatment: A post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial
- Miao Y, Ottenbros SA, Laverman GD, Brenner BM, Cooper ME, Parving HH, Grobbee DE, Shahinfar S, de Zeeuw D, Lambers Heerspink HJ. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial. Hypertension. 2011;58:2-7.
- (2011) Hypertension , vol.58 , pp. 2-7
- Miao, Y.¹ Ottenbros, S.A.² Laverman, G.D.³ Brenner, B.M.⁴ Cooper, M.E.⁵ Parving, H.H.⁶ Grobbee, D.E.⁷ Shahinfar, S.⁸ De Zeeuw, D.⁹ Lambers Heerspink, H.J.¹⁰

2
- 0141957538
- Uric acid reduces exercise-induced oxidative stress in healthy adults
- DOI 10.1042/CS20030149
- Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond). 2003;105:425-430. (Pubitemid 37249168)
- (2003) Clinical Science , vol.105 , Issue.4 , pp. 425-430
- Waring, W.S.¹ Convery, A.² Mishra, V.³ Shenkin, A.⁴ Webb, D.J.⁵ Maxwell, S.R.J.⁶

3
- 52049097771
- Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis
- Raichlin E, Prasad A, Mathew V, Kent B, Holmes DR Jr, Pumper GM, Nelson RE, Lerman LO, Lerman A. Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis. Hypertension. 2008;52:522-528.
- (2008) Hypertension , vol.52 , pp. 522-528
- Raichlin, E.¹ Prasad, A.² Mathew, V.³ Kent, B.⁴ Holmes Jr., D.R.⁵ Pumper, G.M.⁶ Nelson, R.E.⁷ Lerman, L.O.⁸ Lerman, A.⁹

4
- 80051475258
- Chronic selective endothelin a receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease
- Dhaun N, Johnston NR, Goddard J, Webb DJ. Chronic selective endothelin a receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease. Hypertension. 2011;58:11-12.
- (2011) Hypertension , vol.58 , pp. 11-12
- Dhaun, N.¹ Johnston, N.R.² Goddard, J.³ Webb, D.J.⁴

5
- 33645472590
- The endothelin system and its antagonism in chronic kidney disease
- Dhaun N, Goddard J, Webb DJ. The endothelin system and its antagonism in chronic kidney disease. J Am Soc Nephrol. 2006;17:943-955.
- (2006) J Am Soc Nephrol , vol.17 , pp. 943-955
- Dhaun, N.¹ Goddard, J.² Webb, D.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.